Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Press Releases
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at media@evaluate.com.
Latest Press Releases
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
LONDON, BOSTON, TOKYO (September 28, 2021) - The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of…
MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape
LONDON, BOSTON, TOKYO (August 20, 2021) – By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial…
Evaluate Group Limited appoints Cem Baydar as Chief Consulting Officer
LONDON, BOSTON, TOKYO (June 21, 2021) – Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is pleased to…
Browse the archive
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
LONDON, BOSTON, TOKYO (September 28, 2021) - The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of…
MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape
LONDON, BOSTON, TOKYO (August 20, 2021) – By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial…
Evaluate Group Limited appoints Cem Baydar as Chief Consulting Officer
LONDON, BOSTON, TOKYO (June 21, 2021) – Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is pleased to…
Evaluate acquires Bioscience Advisors, adding the most comprehensive database of biopharma deals to its commercial intelligence portfolio
Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has completed the…
Evaluate Vantage 2020 Review: Biopharma IPOs and venture financing break records; global drug stocks add half a trillion dollars in market capitalization
The top 600 biopharma firms added $487 billion in market capitalisation in 2020, according to the Evaluate Vantage Pharma, Biotech & Medtech 2020 in Review report,…
Inova and BIO, in partnership with Evaluate, announce a new series of therapeutic-specific Virtual Partnering events for 2021
Inova and the Biotechnology Innovation Organization (BIO), in partnership with Evaluate announce the second annual series of Virtual Partnering events focused on critical…
Evaluate Vantage 2021 Preview: High hopes and valuations set the tone for biopharma
COVID-19 will continue to be a defining issue for pharma and biotech companies in 2021, but overall the sector will start the year from a position of strength, according…
Evaluate Ltd. launches Evaluate Omnium, transforming pharma’s approach to quantifying the risk and return of novel drugs
Game-changing offering leverages the power of machine learning to fill critical information gaps in the early-stage pharmaceutical pipeline.
Evaluate Ltd. secures additional investment from Hg to drive further growth and expansion
Evaluate Ltd., a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, today announces that it has secured additional…
What crisis? Biopharma rallies strongly after COVID-19 shock: New report from Evaluate Vantage
“Pharma, Biotech and Medtech Half-Year Review 2020” analyses the market performance and deal landscape for the first half of 2020, focusing on the impact of COVID-19
